Indications and pathways of Type 2 diabetes mellitus as a predictor of neurocognitive decline and dementia: Clinical implications and management

More on Type 2 diabetes

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• High neutrophil-to-lymphocyte ratio predicts cognitive decline

  Frontiers in Aging Neuroscience · 4 Oct 2026

• Hypertension links to lower dementia risk in carotid disease

  Research Square · 4 Oct 2026